
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global real world evidence solutions market size reached approximately USD 2.00 Billion in 2024. The market is projected to grow at a CAGR of 12.60% between 2025 and 2034, reaching a value of around USD 6.55 Billion by 2034.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
12.6%
Value in USD Billion
2025-2034
Real World Evidence Solutions Market Outlook
*this image is indicative*
Real world evidence (RWE) solutions refer to methods, approaches, and technologies used to gather and analyse data from real world sources outside of traditional clinical trials. These solutions aim to generate insights and evidence regarding the safety, effectiveness, and value of medical products and interventions in real world settings.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Real World Evidence Solutions Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Component
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
CAGR 2025-2034 - Market by | Country |
India | 15.9% |
Canada | 15.6% |
USA | 13.5% |
China | 13.3% |
Australia | 10.3% |
Japan | 9.0% |
UK | XX% |
Germany | XX% |
France | XX% |
Italy | XX% |
Saudi Arabia | XX% |
Brazil | XX% |
Mexico | XX% |
The utilisation of RWE solutions in drug development and approvals is expected to significantly increase in the projected period. These solutions offer pharmaceutical companies and healthcare providers and payers efficient operational management capabilities, thereby expediting the drug development and approval process.
Healthcare companies are expected to account for the majority of the real world evidence solutions market share. This is primarily attributed to the increasing significance of real world evidence (RWE) studies in the drug approval process, evaluation of drug performance in real world settings, and mitigation of the risk of drug recalls.
Real world evidence plays a crucial role in several important processes. It aids in identifying the specific patient cohorts that can derive the most benefit from a particular intervention or treatment. By analysing real world data, healthcare companies can understand how interventions perform in diverse patient populations, helping them tailor therapies to maximise efficacy.
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global real world evidence solutions market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments and expansion plans.
Iqvia Holdings Inc. is a multinational company that provides information, technology, and services to the healthcare industry. Formerly known as Quintiles IMS Holdings, the company changed its name to Iqvia in November 2017. The services offered by the company include clinical research services, real world data analytics, commercial solutions, and technology platforms.
Thermo Fisher Scientific Inc. is one of the largest companies in the scientific research and laboratory equipment sector. It is an American corporation that offers a wide range of scientific research services, laboratory equipment, reagents, consumables, software, and related services. It was established in 2006 as a result of the merger between Thermo Electron Corporation and Fisher Scientific International Inc. The company's headquarters are presently located in Massachusetts, the United States.
Parexel International Corporation is a leading global clinical research organisation (CRO) that provides a wide range of services to the biopharmaceutical and medical device sector. The company was founded in 1982 and is headquartered in North Carolina, the United States. Parexel offers services throughout the drug development lifecycle, from early-phase clinical trials to post-approval studies.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include PerkinElmer Inc, ICON plc, Syneos Health, Medpace Holdings, Inc, Flatiron Health, Inc., SAS Institute Inc., and Cardinal Health, Inc among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2024, the market reached a value of around USD 2.00 Billion.
The market is projected to grow at a CAGR of 12.60% between 2025 and 2034.
The market is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach around USD 6.55 Billion by 2034.
The market is being driven by the increasing demand for real world evidence solutions from the healthcare sector and the rising implementation of RSE solutions to gain insights from big data sets.
The major trends propelling the market growth include the implementation of real world evidence in regulatory decision-making and the utilisation of advanced technologies such as artificial intelligence and machine learning.
The major regional market includes North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The major end users of real world evidence are healthcare providers, healthcare payers, and pharmaceutical and medical device companies, among others.
The key players in the real world evidence solutions market include Iqvia Holdings Inc., Thermo Fisher Scientific Inc., Parexel International Corporation, PerkinElmer Inc, ICON plc, Syneos Health, Medpace Holdings, Inc, Flatiron Health, Inc., SAS Institute Inc., and Cardinal Health, Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2024 |
Historical Period | 2018-2024 |
Forecast Period | 2025-2034 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Component |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.